Immunology, Infection, and Inflammation Program
Tumor cells often involve changes that should make them appear 'foreign' to the body's immune system. Thus, these tumors must develop strategies to either suppress or evade the patient's immune system. There is tremendous therapeutic potential in working to strengthen the patient's immune response to the tumor, as well as the potential for artificially inducing an appropriate immune response against a tumor. These types of therapies are often very effective as an adjunct to more traditional therapies and add another valuable tool to the translational arsenal.
| Arnold H. Zea, Ph.D.- LSU |
Augusto Ochoa, M.D. - LSU |
| Diego Aviles - LSU |
Ivona V. Pandrea, M.D., Ph.D. - Tulane |
| John Estrada, MD - LSU |
Jovany Zabaleta, Ph.D - LSU |
| Michael Lan - LSU |
Shulin Li - LSU |
| Madhwa H. G. Raj, MSc, PhD - LSU |
Dario Marchetti - LSU |
| Maureen Shuh, Ph.D. - Xavier |
Michael Hagensee, M.D. - LSU |
| Cleveland Moore - LSU |
Seth Pincus - LSU |
| Alistair Ramsay - LSU |
Samuel J. Landry, Ph.D. - Tulane |
| Judd Shellito - LSU |
Srikanta Dash, Ph.D. - Tulane |
| Joy Sturtevant - LSU |
Vecihi Batuman, M.D. - Tulane |
| Julia Volaufova - LSU |
Yan Cui, Ph.D. - LSU |
|
|